Kiniksa Pharmaceuticals, Ltd. revenue breakdown overview

Kiniksa Pharmaceuticals, Ltd. revenue for the last year amounted to 423.24 M USD, the most of which — 423.24 M USD — came from its highest performing source at the moment, Therapeutic Medicines, the year earlier bringing 270.26 M USD. The greatest contribution to the revenue figure was made by Bermuda — last year it brought Kiniksa Pharmaceuticals, Ltd. 423.24 M USD, and the year before that — 270.26 M USD.